UnitedHealth Group Incorporated (UNH) — closed signal from December 3, 2025
Partial Published before the outcome was known, scored automatically when the window closed on March 3, 2026.
Predicted vs. what happened
What happened
Reached 73% of the predicted growth at its peak, without hitting the target.
The thesis — published December 3, 2025
UnitedHealth looks like a high-quality company trading at a discount after sector pressure. Recent price signals have turned more positive and momentum is recovering, suggesting a possible base. Analysts note the stock trades at a mid-teens earnings multiple and a new WeeklyPay ETF shows ongoing demand, which could support a gradual rebound despite policy risk.
Primary drivers
- Recent positive price signals and a stabilizing recent average price hint at recovery.
- Shares trade at a mid-teens earnings multiple, making valuation less stretched.
- A new WeeklyPay ETF shows continued investor interest in the stock.
- Wide mix of health benefits and services supports steady long-term earnings.
How it played out
UNH: target missed after a partial rebound
Lyra published UNH at 324.75 on 2025-12-03 with expected growth of 14%. The thesis pointed to recent positive price signals, a stabilizing recent average price, a mid-teens earnings multiple, a new WeeklyPay ETF, and a wide mix of health benefits and services. It expected a gradual rebound despite policy risk.
Inside the window, UNH rose to 357.87 on 2026-01-23, a peak gain of 10.2%. That stayed below the 367.74 target, so the target was never reached. By 2026-03-03, the stock ended at 289.21. The thesis partly played out, then failed to hold.
What happened during the window
On Jan. 27, 2026, MarketWatch reported that UnitedHealth issued a 2026 revenue outlook for a decline and reported fourth-quarter results. The same article reported that the stock closed lower that day.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.